Data / Drug companies / Reliable 1 Laboratories LLC
Reliable 1 Laboratories LLC: 32 products in the FDA NDC directory, labeler code 69618
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Reliable 1 Laboratories LLC (labeler code 69618) lists 32 products in the FDA National Drug Code Directory, covering 24 finished drugs by generic name. By type: 32 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on May 4, 2026.
The request: Watch Reliable 1 Laboratories LLC (FDA labeler code 69618): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69618
- Products in commercial distribution
- 32
- Packages
- 39
- Finished drugs by generic name
- 24
- Prescription products
- 0
- Over the counter products
- 32
- Flagged as original packager
- 32 of 32 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- November 1, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 30 | 93.8% |
| Generic drugs (ANDA) | 2 | 6.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 32 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Simethicone | 3 | 86 |
| Lidocaine | 2 | 216 |
| Acetaminophen | 2 | 214 |
| Diphenhydramine hcl | 2 | 99 |
| Sennosides | 2 | 65 |
| Guaifenesin | 2 | 123 |
| Aspirin | 2 | 134 |
| Meclizine hcl 12.5 mg | 1 | 6 |
| Carboxymethylcellulose sodium 0.5% solution | 1 | 1 |
| Meclizine hcl | 1 | 32 |
| Menthol, zinc oxide | 1 | 5 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Sodium chloride hypertonicity ophthalmic solution, 5% | 1 | 1 |
| Ibuprofen | 1 | 190 |
| Docusate sodium | 1 | 79 |
| Sodium bicarbonate | 1 | 51 |
| Camphor, menthol, white petrolatum | 1 | 1 |
| Mineral oil, white petrolatum | 1 | 3 |
| Sennosides, docusate sodium | 1 | 4 |
| Calcium carbonate | 1 | 101 |
| Omeprazole | 1 | 106 |
| Esomeprazole magnesium | 1 | 77 |
| Bismuth subsalicylate | 1 | 80 |
| Oxymetazoline hydrochloride | 1 | 64 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 9 | 28.1% |
| Tablet, chewable | 4 | 12.5% |
| Ointment | 3 | 9.4% |
| Solution/ drops | 2 | 6.2% |
| Liquid | 2 | 6.2% |
| Patch | 1 | 3.1% |
| Capsule | 1 | 3.1% |
| Suspension | 1 | 3.1% |
| Capsule, liquid filled | 1 | 3.1% |
| Tablet, soluble | 1 | 3.1% |
| Tablet, coated | 1 | 3.1% |
| Suspension/ drops | 1 | 3.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Reliable-1 anti drip pump mist | 69618-716 | Spray | Over the counter monograph drugs | May 4, 2026 |
| Stool Softener | 69618-086 | Capsule, liquid filled | Over the counter monograph drugs | September 1, 2025 |
| Retalief lidocaine 5 | 69618-075 | Cream | Over the counter monograph drugs | January 20, 2025 |
| Pain Relief Patch 4% Lidocaine | 69618-082 | Patch | Over the counter monograph drugs | January 13, 2025 |
| Sodium Chloride Hypertonicity Ophthalmic Solution, 5% | 69618-077 | Solution/ drops | Over the counter monograph drugs | December 27, 2024 |
| Childrens Ibuprofen Oral Suspension | 69618-078 | Suspension | Over the counter monograph drugs | December 2, 2024 |
| Lubricating Tears | 69618-076 | Solution/ drops | Over the counter monograph drugs | December 2, 2024 |
| Reliable-1 Tussin | 69618-068 | Liquid | Over the counter monograph drugs | December 1, 2024 |
| Esomeprazole magnesium | 69618-073 | Capsule, delayed release | Generic drugs (ANDA) | April 14, 2023 |
| Tussin DMMax | 69618-072 | Liquid | Over the counter monograph drugs | December 1, 2022 |
| Lubricant Eye PM | 69618-060 | Ointment | Over the counter monograph drugs | January 1, 2022 |
| Senna | 69618-069 | Syrup | Over the counter monograph drugs | August 3, 2021 |
| Acid Reducer | 69618-054 | Tablet, delayed release | Generic drugs (ANDA) | March 11, 2021 |
| Calprotect | 69618-067 | Ointment | Over the counter monograph drugs | January 1, 2021 |
| Aspirin 81 mg | 69618-066 | Tablet, coated | Over the counter monograph drugs | October 1, 2020 |
| Sennosides and Docusate Sodium | 69618-065 | Tablet | Over the counter monograph drugs | August 1, 2020 |
| Senna | 69618-064 | Tablet | Over the counter monograph drugs | August 1, 2020 |
| Guaifenesin | 69618-061 | Tablet | Over the counter monograph drugs | August 1, 2020 |
| Infants gas relief drops | 69618-059 | Suspension/ drops | Over the counter monograph drugs | February 1, 2020 |
| Boroleum | 69618-052 | Ointment | Over the counter monograph drugs | April 16, 2019 |
| Simethicone 125 mg | 69618-032 | Tablet, chewable | Over the counter monograph drugs | April 25, 2018 |
| Simethicone 80 mg | 69618-033 | Tablet, chewable | Over the counter monograph drugs | April 24, 2018 |
| Sodium Bicarbonate 10 gr | 69618-034 | Tablet, soluble | Over the counter monograph drugs | November 1, 2015 |
| Bismuth Subsalicylate 262 mg | 69618-029 | Tablet, chewable | Over the counter monograph drugs | November 1, 2015 |
| Meclizine HCL 25 mg | 69618-028 | Tablet | Over the counter monograph drugs | November 1, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.